Filing Details
- Accession Number:
- 0001209191-17-046031
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-07-21 20:10:39
- Reporting Period:
- 2017-07-19
- Filing Date:
- 2017-07-21
- Accepted Time:
- 2017-07-21 20:10:39
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 875320 | Vertex Pharmaceuticals Inc / Ma | VRTX | Pharmaceutical Preparations (2834) | 043039129 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1446372 | M Paul Silva | C/O Vertex Pharmaceuticals Incorporated 50 Northern Avenue Boston MA 02210 | Svp & Corp Controller | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2017-07-19 | 6,445 | $77.31 | 26,516 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2017-07-19 | 4,500 | $48.74 | 31,016 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2017-07-19 | 8,438 | $45.11 | 39,454 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2017-07-19 | 3,437 | $83.36 | 42,891 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2017-07-19 | 3,437 | $96.87 | 46,328 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2017-07-19 | 3,867 | $109.14 | 50,195 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2017-07-19 | 6,445 | $91.05 | 56,640 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2017-07-19 | 3,437 | $90.29 | 60,077 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2017-07-19 | 40,006 | $161.00 | 20,071 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2017-07-21 | 2,937 | $161.91 | 17,134 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2017-07-21 | 500 | $161.92 | 16,634 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2017-07-19 | 6,445 | $0.00 | 6,445 | $77.31 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2017-07-19 | 4,500 | $0.00 | 4,500 | $48.74 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2017-07-19 | 8,438 | $0.00 | 8,438 | $45.11 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2017-07-19 | 3,437 | $0.00 | 3,437 | $83.36 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2017-07-19 | 3,437 | $0.00 | 3,437 | $96.87 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2017-07-19 | 3,867 | $0.00 | 3,867 | $109.14 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2017-07-19 | 6,445 | $0.00 | 6,445 | $91.05 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2017-07-19 | 3,437 | $0.00 | 3,437 | $90.29 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 3,867 | 2024-02-04 | No | 4 | M | Direct | |
| 0 | 2022-07-24 | No | 4 | M | Direct | |
| 0 | 2023-02-04 | No | 4 | M | Direct | |
| 860 | 2023-07-29 | No | 4 | M | Direct | |
| 10,313 | 2024-07-14 | No | 4 | M | Direct | |
| 16,758 | 2025-02-02 | No | 4 | M | Direct | |
| 14,180 | 2026-02-01 | No | 4 | M | Direct | |
| 10,313 | 2026-07-11 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 169 | Indirect | 401k |
Footnotes
- Transaction made pursuant to Mr. Silva's company-approved trading plan under Rule 10b5-1.
- The option vests in 16 quarterly installments from 2/5/2014.
- Fully vested.
- The option vests in 16 quarterly installments from 7/30/2013.
- The option vests in 16 quarterly installments from 7/15/2014.
- The option vests in 16 quarterly installments from 2/3/2015.
- The option vests in 16 quarterly installments from 2/2/2016.
- The option vests in 16 quarterly installments from 7/12/2016.
Billionaire Hedge Funds
